MYP_025895
Basic Information
E1P46-2
Antimicrobial
Antiviral
Antiviral Anti-HIV Anti-HIV-1
Antiviral Antiviral mechanism Viral fusion inhibition
Standard
18 amino acids
C125H165N25O25
Standard
Sequence
YWILEYLWKVPFDFWRGV
Physicochemical Analysis
2417.80 Da
6.07
-0.24
-0.45
-0.0133
0.19
0.61
0.33
42.17
97.22
0.3889
19480.00
19480.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
799.58
3.51
29.0
25.0
69.0
175.0
11.0
17.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0179477 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Aurein
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
HIV-1 NL4-3
32.3±11 μM
IC50
RECORD: Rec_0181792 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
Virus:HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells
32.3±11 μM
IC50
RECORD: Rec_0281856 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 NL4-3 | TZM-bl cells
32.3±11 μM
IC50
Mammalian: 2.8 h; Yeast: 10 min; E. coli: 2 min